Gilead (GILD) CFO Andrew Dickinson Exercises RSUs; Shares Withheld

What Happened

• Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, converted/settled 2,797 restricted stock units (RSUs) into common shares on September 10, 2026. To cover tax withholding obligations, 1,347 of those shares were surrendered (disposed) at $144.81 per share, totaling $195,059. The filing shows the RSU conversion and the tax-withholding share disposition.

Key Details

• Transaction date: September 10, 2026; Form 4 filed September 11, 2026 (filed one day after the transaction).
• Shares converted/received: 2,797 RSUs converted into shares (derivative conversion).
• Shares surrendered for taxes: 1,347 shares disposed at $144.81 each for $195,059.
• Shares owned after transaction: Not specified in the provided filing data.
• Footnotes: F1 — each RSU equals the contingent right to one share; F2 — RSUs follow a 4-year vesting schedule (25% after one year, then 6.25% quarterly).
• Transaction types: M = exercise/conversion of a derivative (RSU settlement); F = shares withheld/used to pay tax liability (not an open-market sale).

Context

• This was an RSU settlement with shares withheld to satisfy withholding tax obligations — common, administrative insider activity rather than an intentional market-sale signal.
• Because the filing reflects tax withholding rather than an open-market sale, it’s primarily a routine liquidity/compensation event.